The Huber Needles Market is gaining momentum as healthcare providers increasingly rely on specialized medical devices for safe and efficient access to implanted vascular access ports. Huber needles are non-coring needles designed to access implantable ports used for administering medications, fluids, chemotherapy, and other treatments.
Market Overview
The global huber needles market size is projected to reach US$ 134.23 million by 2034 from US$ 75.38 million in 2025. The market is anticipated to register a CAGR of 6.62% during the forecast period 2026-2034.Huber needles are widely used in hospitals, oncology centers, infusion clinics, and other healthcare facilities. Unlike conventional hypodermic needles, their angled, non-coring tips are designed to penetrate the septum of an implanted port without removing material from it. This helps maintain the functionality of vascular access devices during repeated clinical procedures.
These needles are available in different lengths, gauges, and configurations to accommodate patient requirements and treatment settings. Safety-engineered Huber needles, including products with protective mechanisms, are gaining attention because they help reduce accidental needlestick injuries among healthcare professionals. Manufacturers are focusing on ergonomic designs, improved needle stability, and user-friendly safety features to support clinical efficiency.
Download Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00016873
Key Drivers Supporting Market Growth
Increasing Prevalence of Cancer
The growing burden of cancer is a major factor supporting demand for Huber needles. Many cancer patients require repeated administration of chemotherapy, supportive medications, and intravenous fluids. Implanted vascular access ports provide a convenient route for long-term treatment, creating demand for specialized non-coring needles used to access these devices.
Growing Adoption of Implantable Vascular Access Ports
Implantable ports are increasingly used for patients requiring frequent or long-term intravenous therapy. These devices reduce the need for repeated peripheral venous access and can support treatment continuity. As the use of implanted ports expands across oncology and other therapeutic areas, demand for compatible Huber needles is also increasing.
Rising Focus on Needlestick Injury Prevention
Needlestick injuries pose occupational risks to healthcare professionals. Hospitals are therefore emphasizing the use of safety-engineered medical devices that help reduce accidental exposure to bloodborne pathogens. Safety Huber needles with protective mechanisms are gaining adoption as healthcare facilities strengthen workplace safety practices.
Expansion of Infusion Therapy Services
The growing use of infusion therapy for cancer, chronic diseases, and other medical conditions is creating demand for reliable vascular access products. Hospitals, specialty clinics, and outpatient infusion centers require Huber needles to administer treatments through implanted ports while supporting patient comfort and procedural safety.
Regional Analysis
North America represents an important region in the Huber needles market, supported by established healthcare infrastructure, advanced oncology services, and widespread use of implantable vascular access ports. Hospitals and infusion centers across the United States and Canada are increasingly adopting safety-engineered needle products to support treatment delivery and healthcare worker protection.
Europe is supported by established cancer care facilities, growing adoption of infusion therapies, and increasing emphasis on occupational safety in healthcare environments. Asia Pacific offers growth opportunities through expanding healthcare infrastructure, rising cancer care demand, and greater access to specialized treatment services. Meanwhile, Latin America and the Middle East and Africa are gradually expanding oncology and infusion care capabilities, creating opportunities for medical device manufacturers.
Get Full Report: https://www.theinsightpartners.com/buy/TIPRE00016873
Competitive Landscape and Key Players
Companies operating in the Huber needles market focus on product innovation, safety features, manufacturing quality, regulatory compliance, and distribution expansion. Manufacturers are developing specialized needle configurations and integrated access sets to address the requirements of hospitals, oncology centers, and infusion clinics.
Key players include:
-
B. Braun SE
-
Becton, Dickinson and Company
-
ICU Medical, Inc.
-
Baxter International Inc.
-
Nipro Corporation
-
Smiths Medical
-
AngioDynamics, Inc.
-
Vygon SA
-
Teleflex Incorporated
-
Merit Medical Systems, Inc.
-
C. R. Bard, Inc. (part of BD)
-
Cook Medical
Challenges in the Huber Needles Market
Despite increasing demand, the market faces challenges related to product costs, regulatory requirements, and the need for proper clinical training. Incorrect needle selection, improper insertion, or inadequate securement can contribute to complications such as port damage, leakage, infection, or treatment interruption.
Healthcare facilities must also ensure compatibility between Huber needles and implanted port systems. Differences in port design, needle length, and gauge requirements can influence product selection. Manufacturers must maintain consistent product quality while meeting applicable medical device safety standards.
Future Opportunities
The Huber needles market offers opportunities through the development of advanced safety-engineered products, improved needle designs, and integrated vascular access solutions. Growing demand for oncology treatment, outpatient infusion services, and long-term intravenous therapies is expected to support product adoption. Manufacturers can strengthen their market position through research and development, partnerships with healthcare providers, and expansion into emerging healthcare markets.
Related Reports
Tenofovir Disoproxil Fumarate Market Trends , Share & Demand by 2034
Thermal Analysis Market Statistics , Trends, Size, Share, Analysis, Key Players by 2031
About Us
The Insight Partners provides comprehensive syndicated and tailored market research services in the healthcare, technology, and industrial domains. Renowned for delivering strategic intelligence and practical insights, the firm empowers businesses to remain competitive in ever-evolving global markets.
Contact Us
Contact Person: Ankit Mathur
Email: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876
Also Available in : Korean German Japanese French Chinese Italian Spanish
